The Best Trillion-Dollar Stock to Buy Now, According to Wall Street Analysts

Microsoft reported Azure revenue growth of 40% and commercial software sales growth of 19%, while Microsoft 365 Copilot seat additions rose 250% year over year to over 20 million users. Management also guided to a sharp increase in calendar 2026 capex, now $190 billion, which has pressured the stock despite continued earnings growth of 21% in the quarter. Wall Street's median price target is $550, implying the stock has notable upside over the next 12 months.

Analysis

The market is treating Microsoft’s capex surge as a margin problem, but the more important read-through is that the company is effectively pre-committing to defend its position in the AI compute stack. That tends to favor the supplier ecosystem first: hyperscale infrastructure, networking, power, and advanced semis should see the incremental dollar before Microsoft monetization fully catches up. The key second-order effect is that Microsoft can temporarily suppress free cash flow while still increasing strategic optionality; that usually benefits long-duration asset owners more than near-term cash yield seekers.

The consensus mistake is assuming higher spend automatically means lower returns. In a platform business with multiple monetization layers, the first return often appears in retention and wallet-share before it shows up in headline operating margin. The faster Copilot adoption matters because it raises switching costs across enterprise workflows, which can widen Microsoft’s pricing power over the next 12-24 months even if Azure growth normalizes from its current pace.

The real risk is not the size of capex but misallocation: if incremental spend goes to training and inference capacity that under-penetrates enterprise demand, the market will eventually re-rate the stock from ‘compounder’ to ‘capital-intensive utility.’ That would show up over the next two to three quarters as decelerating growth with no commensurate margin protection. A smaller but important tail risk is that AI leaders across the sector begin to race each other into oversupply, pressuring compute pricing and extending payback periods.

Contrarian takeaway: the stock may be cheap not because the business is weak, but because investors are applying a mature software multiple to a platform still in investment mode. If management’s spend translates into product-led lock-in, the multiple can re-expand without needing heroic revenue acceleration. If not, the downside is mostly valuation compression rather than business impairment, which is why this looks more like a timing opportunity than a fundamental short.

Key Decisions for Investors

• Long MSFT on a 6-12 month horizon; use pullbacks into 24-25x forward earnings as entry, with a base case of multiple re-rating if AI attach rates keep rising. Risk: if capex keeps climbing while Azure growth slows, expect 10-15% downside from multiple compression.
• Pair long MSFT / short a basket of lower-quality AI beneficiaries with weaker balance sheets over 3-6 months; thesis is that only platform owners can convert AI spend into durable cross-sell, while marginal names remain cash-flow constrained.
• Overweight NVDA on 3-9 months as a second-order beneficiary of Microsoft’s spend cadence; the risk/reward is favorable because hyperscale demand remains the gating factor for GPU utilization. Main risk: any capex pause or supply digestion could trigger a sharp air-pocket in the stock.
• Add to semicap and networking exposure on weakness rather than chasing Microsoft directly; the capex ramp should propagate through the supply chain before it appears in broader enterprise software spending. Use a 1-2 quarter window, with tighter stops if cloud order commentary softens.
• Avoid shorting MSFT outright; if the market is wrong, the squeeze is large because the downside is limited by recurring revenue strength while upside comes from both earnings growth and multiple expansion.